Studies have shown that mutations in the catenin beta1 (CTNNB1) gene, which encodes β‐catenin, are present in about 12% of HBV–HCC patients and directly cause abnormal activation of the Wnt/β‐catenin pathway [450]. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.